Antiaggregant agents have meant a great advance in the treatment of CVA. In view of the relatively modest degree of protection given by Aspirin, future strategies will probably include combining it with other antiaggregant agents, antithrombotic drugs and neuroprotectors.
Paul A. GurbelRahil RafeedheenUdaya S. Tantry
Verónica Diez DiezÁngeles Morales Martínez
A. de la Sierra IserteAntonio Coca Payeras
J J Muñoz-TorreroFrancisco MoraExuperio Díez‐Tejedor